US plans steep countervailing duties on solar imports from India, prompting module makers to explore alternative markets and ...

Don't underestimate Samsung's handy side-swipe menu ...

G-Shock took its toughest watch yet to one of Scotland's most brutal mountains ...

It's a first-entry to the world of Meshtastic.

As we move further into 2026, many leaders find themselves with a similar challenge, despite having invested heavily in AI tools, adoption is patchy and ROI is wide of the mark. They’re well aware of ...

Disney turns its alien war machine into a tame teen franchise. Can the 4K UHD convince at least technically?

The jumping hour watch is having its cushion-case moment. Roughly a century after the first jumping hour watches graced the wrists of enthusiasts the world over, we’re witnessing a resurgence ...

Porsche has pulled the covers off the new Porsche Cayenne S Electric — slotting neatly between the base Cayenne Electric and the range-topping Cayenne ...

Compass International Holdings has named a new president of the Compass brokerage operation. In a LinkedIn post on Monday night, Robert Reffkin, the CEO and chairman of Compass International Holdings, ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways on ...

Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depression (TRD) ...